Joshua Reed
2023 - Omega Therapeutics
In 2023, Joshua Reed earned a total compensation of $907K as Chief Financial Officer at Omega Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $182,988 |
|---|---|
| Option Awards | $247,610 |
| Salary | $465,000 |
| Other | $11,400 |
| Total | $906,998 |
Reed received $465K in salary, accounting for 51% of the total pay in 2023.
Reed also received $183K in non-equity incentive plan, $247.6K in option awards and $11.4K in other compensation.
Rankings
In 2023, Joshua Reed's compensation ranked 1,299th out of 2,878 executives tracked by ExecPay. In other words, Reed earned more than 54.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,299 out of 2,878 | 55th |
Division Manufacturing | 784 out of 1,582 | 50th |
Major group Chemicals And Allied Products | 519 out of 891 | 42nd |
Industry group Drugs | 506 out of 854 | 41st |
Industry Biological Products, Except Diagnostic Substances | 145 out of 209 | 31st |
Source: SEC filing on April 29, 2024.
Reed's colleagues
We found two more compensation records of executives who worked with Joshua Reed at Omega Therapeutics in 2023.